Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Consolidated Net Profit

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹1,885 Cr₹1,388 Cr₹715 Cr₹170 Cr₹441 Cr

What is the latest Consolidated Net Profit of NATCO PHARMA ?

The latest Consolidated Net Profit ratio of NATCO PHARMA is ₹1,885 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹1,885 Cr
Mar2024₹1,388 Cr
Mar2023₹715 Cr
Mar2022₹170 Cr
Mar2021₹441 Cr

How is Consolidated Net Profit of NATCO PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹1,885 Cr
35.81
Mar2024 ₹1,388 Cr
94.09
Mar2023 ₹715 Cr
320.76
Mar2022 ₹170 Cr
-61.44
Mar2021 ₹441 Cr -

Compare Consolidated Net Profit of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,571.8 Cr -8.2% -4% -33.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,037.0 Cr -3% -3.6% -4.9% Stock Analytics
DIVIS LABORATORIES ₹170,795.0 Cr -3.1% 0.1% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,332.0 Cr -3.7% 4% 18.8% Stock Analytics
CIPLA ₹116,933.0 Cr -1.3% -4.6% -1.5% Stock Analytics
DR REDDYS LABORATORIES ₹99,350.2 Cr -4.2% -7% -11.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-8.2%

-4%

-33.3%

SENSEX

-1.7%

-1.4%

7%


You may also like the below Video Courses